Abstract

Using various methods, we will attempt to determine the immunologic capacity of T cells from HIV+ individuals. In addition to decreased numbers of CD4+ T cells, it has been suggested that there is also a qualitative defect. Therefore, T cells from HIV+ individuals will be examined carefully and compared with those from normal individuals.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI041381-04
Application #
6163920
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Program Officer
Kagan, Jonathan M
Project Start
1997-03-01
Project End
2001-02-28
Budget Start
2000-03-01
Budget End
2001-02-28
Support Year
4
Fiscal Year
2000
Total Cost
$284,444
Indirect Cost

  Institution

Name
Weill Medical College of Cornell University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065

  Publications

Smith, K A (1997) Rational interleukin-2 therapy. Cancer J Sci Am 3 Suppl 1:S137-40